The insight into VWF:FVIII complex formation facilitate the design of improved hemophilia A treatments, whereas the analysis of VWD mutations provides a link between genetic pathology and clinical phenotype to facilitate targeted management of patients with VWD. The gene discussed is F8; the disease is von Willebrand disease (hereditary or acquired).